Regulatory Considerations for Microbiome Based Therapeutics
Time: 11:30 am
day: Conference Day One Track C AM 1
Details:
- An overview of CMC requirements for Live Biotherapeutic Products
- Discussion of assays for product characterization and release
- Presentation of proof of principle study assessing the use of MALDI-TOF for single strain enumeration from multi-strain mixtures
